DAVIDE CAMPARI-MILANO NV (CPR.MI) Stock Fundamental Analysis
BIT:CPR - Euronext Milan - NL0015435975 - Common Stock - Currency: EUR
Taking everything into account, CPR scores 4 out of 10 in our fundamental rating. CPR was compared to 27 industry peers in the Beverages industry. Both the profitability and the financial health of CPR get a neutral evaluation. Nothing too spectacular is happening here. While showing a medium growth rate, CPR is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
CPR had positive earnings in the past year.
In the past year CPR had a positive cash flow from operations.
In the past 5 years CPR has always been profitable.
CPR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 2.38%, CPR is in line with its industry, outperforming 40.74% of the companies in the same industry.
Looking at the Return On Equity, with a value of 5.23%, CPR is in line with its industry, outperforming 40.74% of the companies in the same industry.
CPR's Return On Invested Capital of 6.63% is in line compared to the rest of the industry. CPR outperforms 48.15% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CPR is in line with the industry average of 8.68%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.38% | ||
| ROE | 5.23% | ||
| ROIC | 6.63% |
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
1.3 Margins
CPR has a Profit Margin of 6.57%. This is comparable to the rest of the industry: CPR outperforms 44.44% of its industry peers.
In the last couple of years the Profit Margin of CPR has declined.
CPR has a Operating Margin of 21.32%. This is comparable to the rest of the industry: CPR outperforms 59.26% of its industry peers.
In the last couple of years the Operating Margin of CPR has remained more or less at the same level.
Looking at the Gross Margin, with a value of 57.55%, CPR is in the better half of the industry, outperforming 70.37% of the companies in the same industry.
In the last couple of years the Gross Margin of CPR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.32% | ||
| PM (TTM) | 6.57% | ||
| GM | 57.55% |
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CPR is creating some value.
The number of shares outstanding for CPR has been increased compared to 1 year ago.
Compared to 5 years ago, CPR has more shares outstanding
CPR has about the same debt/assets ratio as last year.
2.2 Solvency
CPR has an Altman-Z score of 2.40. This is not the best score and indicates that CPR is in the grey zone with still only limited risk for bankruptcy at the moment.
CPR has a Altman-Z score of 2.40. This is in the better half of the industry: CPR outperforms 62.96% of its industry peers.
CPR has a debt to FCF ratio of 13.61. This is a negative value and a sign of low solvency as CPR would need 13.61 years to pay back of all of its debts.
With a Debt to FCF ratio value of 13.61, CPR perfoms like the industry average, outperforming 40.74% of the companies in the same industry.
A Debt/Equity ratio of 0.66 indicates that CPR is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.66, CPR is doing good in the industry, outperforming 70.37% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 13.61 | ||
| Altman-Z | 2.4 |
ROIC/WACC0.95
WACC6.97%
2.3 Liquidity
CPR has a Current Ratio of 2.37. This indicates that CPR is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of CPR (2.37) is better than 77.78% of its industry peers.
CPR has a Quick Ratio of 2.37. This is a bad value and indicates that CPR is not financially healthy enough and could expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 0.99, CPR belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.37 | ||
| Quick Ratio | 0.99 |
3. Growth
3.1 Past
The earnings per share for CPR have decreased strongly by -39.43% in the last year.
The Earnings Per Share has been decreasing by -8.12% on average over the past years.
Looking at the last year, CPR shows a small growth in Revenue. The Revenue has grown by 5.18% in the last year.
The Revenue has been growing by 10.75% on average over the past years. This is quite good.
EPS 1Y (TTM)-39.43%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%-109.15%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%-45.74%
3.2 Future
Based on estimates for the next years, CPR will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.10% on average per year.
The Revenue is expected to grow by 4.93% on average over the next years.
EPS Next Y1.31%
EPS Next 2Y6.65%
EPS Next 3Y8.05%
EPS Next 5Y8.1%
Revenue Next Year5.14%
Revenue Next 2Y5.03%
Revenue Next 3Y5.27%
Revenue Next 5Y4.93%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 32.61, which means the current valuation is very expensive for CPR.
CPR's Price/Earnings ratio is a bit more expensive when compared to the industry. CPR is more expensive than 70.37% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.17. CPR is valued slightly more expensive when compared to this.
Based on the Price/Forward Earnings ratio of 19.52, the valuation of CPR can be described as rather expensive.
CPR's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. CPR is more expensive than 66.67% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.10. CPR is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.61 | ||
| Fwd PE | 19.52 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CPR is valued a bit more expensive than 62.96% of the companies in the same industry.
62.96% of the companies in the same industry are cheaper than CPR, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.35 | ||
| EV/EBITDA | 12.59 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)24.9
PEG (5Y)N/A
EPS Next 2Y6.65%
EPS Next 3Y8.05%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.14%, CPR has a reasonable but not impressive dividend return.
CPR's Dividend Yield is slightly below the industry average, which is at 2.78.
Compared to an average S&P500 Dividend Yield of 2.40, CPR's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.14% |
5.2 History
The dividend of CPR decreases each year by -2.80%.
Dividend Growth(5Y)-2.8%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
38.74% of the earnings are spent on dividend by CPR. This is a low number and sustainable payout ratio.
DP38.74%
EPS Next 2Y6.65%
EPS Next 3Y8.05%
BIT:CPR (5/29/2025, 9:51:14 AM)
5.87
+0.17 (+2.98%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)
Earnings (Next)
Inst Owners23.33%
Inst Owner ChangeN/A
Ins Owners52.32%
Ins Owner ChangeN/A
Market Cap7.23B
Analysts70.71
Price Target7.09 (20.78%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.14% |
Yearly Dividend0.04
Dividend Growth(5Y)-2.8%
DP38.74%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.14%
PT rev (3m)-10.97%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-5.8%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.31%
Revenue NY rev (3m)-0.86%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.61 | ||
| Fwd PE | 19.52 | ||
| P/S | 2.35 | ||
| P/FCF | 34.35 | ||
| P/OCF | 10.78 | ||
| P/B | 1.88 | ||
| P/tB | 158.5 | ||
| EV/EBITDA | 12.59 |
EPS(TTM)0.18
EY3.07%
EPS(NY)0.3
Fwd EY5.12%
FCF(TTM)0.17
FCFY2.91%
OCF(TTM)0.54
OCFY9.28%
SpS2.49
BVpS3.13
TBVpS0.04
PEG (NY)24.9
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.38% | ||
| ROE | 5.23% | ||
| ROCE | 9.04% | ||
| ROIC | 6.63% | ||
| ROICexc | 6.65% | ||
| ROICexgc | 14.08% | ||
| OM | 21.32% | ||
| PM (TTM) | 6.57% | ||
| GM | 57.55% | ||
| FCFM | 6.85% |
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
ROICexc(3y)8.52%
ROICexc(5y)8.34%
ROICexgc(3y)23.37%
ROICexgc(5y)25.9%
ROCE(3y)10.45%
ROCE(5y)9.91%
ROICexcg growth 3Y-20.45%
ROICexcg growth 5Y-21.73%
ROICexc growth 3Y-7.67%
ROICexc growth 5Y-5.91%
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
F-Score4
Asset Turnover0.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 13.61 | ||
| Debt/EBITDA | 3.27 | ||
| Cap/Depr | 360.3% | ||
| Cap/Sales | 14.99% | ||
| Interest Coverage | 6.98 | ||
| Cash Conversion | 85.73% | ||
| Profit Quality | 104.37% | ||
| Current Ratio | 2.37 | ||
| Quick Ratio | 0.99 | ||
| Altman-Z | 2.4 |
F-Score4
WACC6.97%
ROIC/WACC0.95
Cap/Depr(3y)346.34%
Cap/Depr(5y)266.11%
Cap/Sales(3y)12.99%
Cap/Sales(5y)10.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-39.43%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%-109.15%
EPS Next Y1.31%
EPS Next 2Y6.65%
EPS Next 3Y8.05%
EPS Next 5Y8.1%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%-45.74%
Revenue Next Year5.14%
Revenue Next 2Y5.03%
Revenue Next 3Y5.27%
Revenue Next 5Y4.93%
EBIT growth 1Y6.39%
EBIT growth 3Y15.63%
EBIT growth 5Y10.27%
EBIT Next Year23.05%
EBIT Next 3Y13.08%
EBIT Next 5Y11.25%
FCF growth 1Y232.49%
FCF growth 3Y-14.61%
FCF growth 5Y-4.94%
OCF growth 1Y328.44%
OCF growth 3Y11.5%
OCF growth 5Y13.06%